Padua, ITALY | December 18, 2024 - Inventis, a recognized leader in audiology and balance diagnostic solutions, is excited to introduce Celesta, an innovative 2-channel system tailored for auditory and vestibular evoked potentials testing. This state-of-the-art platform delivers exceptional adaptability and scalability, catering to the varying demands of clinicians across diverse medical environments.
Celesta revolutionizes diagnostic workflows and enhances accuracy by seamlessly integrating with Maestro, Inventis's all-in-one software suite. This synergy ensures unified management of Inventis devices, enabling clinicians to efficiently perform sophisticated diagnostic procedures with unmatched flexibility.
The system adopts a modular, scalable design, empowering users to tailor its configuration to their specific requirements. Whether operating in a small clinic or a large hospital setting, Celesta provides powerful capabilities for auditory and vestibular testing, including ABR, eABR, ECochG, MLR, LLR, as well as cervical and ocular VEMP assessments. Additionally, the forthcoming integration of the HEARLab ACA (Aided Cortical Assessment) module—currently under development—will further broaden its functionality.
Smart features have been embedded into the Celesta system to optimize clinical processes and ensure ease of use. Highlights include an automatic single-channel switch, guided electrode connection with LED indicators, software-enabled electrode configuration, and dedicated tests for both cervical and ocular VEMPs. These features simplify system setup while ensuring precise, high-quality results across a wide array of applications.
“Celesta represents an important milestone for Inventis as we expand into the evoked potentials domain, a key element of our strategic growth," said Massimo Martinelli, General Manager of Inventis. “With its intuitive setup, configurable design, seamless integration with Maestro, and intelligent features, Celesta reflects the core values that define Inventis instruments: accessibility, versatility, and a strong commitment to advancing patient care."
Celesta is now open for pre-orders, with the first deliveries expected in early 2025. Availability in the United States will follow at a later date as Inventis completes the required regulatory processes to ensure full compliance with local market standards.
For additional details, please visit: https://www.inventis.it/world/product/celesta-evoked-potentials?noLangModal
ABOUT INVENTIS
Inventis is a high-tech Italian company dedicated to developing and manufacturing cutting-edge devices for audiology and balance diagnostics. Inventis boasts one of the most comprehensive portfolios in the market, including audiometers, middle ear analyzers, solutions for hearing aid fitting, devices for Auditory Evoked Potentials, and balance diagnostics equipment. Today, Inventis has a presence in more than 60 Countries worldwide, supported by direct operations and a network of dedicated, committed local distributors.
